PM360 2021 Trailblazer Awards Consumer Website/Online Initiative Gold Winner Kala Pharmaceuticals and QBFox Healthcomm

EYSUVIS, “MYEYSUVIS” (Kala Pharmaceuticals, QBFox Healthcomm)

The innovative Dry Eye Disease (DED) campaign from EYSUVIS centered around “Droppy,” a stylized blue eyedrop character (based on the EYSUVIS logo) who delivers knowledgeable and reassuring information to patients. As well, “Droppy” shows how EYSUVIS can provide the kind of relief these patients have never seen or experienced before. The character confidently teaches patients about DED and gives them the tools and language to speak with their eye care providers (ECPs) about treatment.

Although the campaign kicked off in the height of the pandemic, more patients than expected are visiting the site, downloading resources, and visiting their ECPs armed with powerful information.

Ads

You May Also Like

PM360 2019 Trailblazer Awards Professional Campaign Winner Novo Nordisk and Concentric Health Experience

“Same Will, New Way” (Novo Nordisk, Concentric Health Experience) Shaping a market that affects ...

PM360 2022 Trailblazer Awards Professional Website/Online Initiative Gold Winner Biofrontera and Elevate Healthcare

Ameluz: When Danger Lurks Below the Surface (Biofrontera and Elevate Healthcare) Approximately 8% to ...

PM360 2021 Innovative Product RxVantage Digital Platform from RxVantage

RxVantage Digital Platform RxVantage Alejandro Villageliu, EVP, Head of Enterprise Partnerships alejandro@rxvantage.com  Keeping up ...